Press Enter to search
.jpg)
Evacuated tube systems are the gold standard for routine venipuncture, but clinical reality frequently demands otherwise. Patients with difficult venous access, pediatric draws, peripheral IV line collections, and certain point-of-care settings all require a syringe-based approach followed by manual transfer of the sample into collection tubes. This step carries well-documented risks—both to healthcare workers and to the integrity of the specimens being collected.
The following is a clinically grounded review of those risks and the device selection and technique strategies that mitigate them.
The most immediate danger of syringe-to-tube transfer is needlestick injury. When a clinician removes the needle from a syringe and attempts to push blood through an open tube cap or when the needle is re-inserted to puncture a stopper, the opportunity for accidental puncture is significant. The hands are close to the needle tip; the tubes may be held in the non-dominant hand or balanced on a tray, and the force required to depress a plunger introduces unpredictability.
According to the Centers for Disease Control and Prevention (CDC), an estimated 385,000 needlestick and sharps-related injuries occur among healthcare workers in U.S. hospital settings each year. Phlebotomy and blood collection activities account for a disproportionate share of these events. Bloodborne pathogen transmission – including hepatitis B, hepatitis C, and HIV – remains a documented consequence of occupational needlestick injury, making prevention a patient safety and a workforce safety imperative simultaneously.
The Needlestick Safety and Prevention Act mandates the use of safety-engineered devices where feasible, and the subsequent OSHA Bloodborne Pathogens Standard requires employers to evaluate and implement safer medical devices. Closed blood transfer devices are directly responsive to this regulatory and ethical mandate.
Beyond the safety implications for clinicians, open syringe-to-tube transfer introduces a cascade of pre-analytical risks that can compromise laboratory results and, in turn, clinical decision-making.
Hemolysis is the most frequently cited consequence of improper syringe transfer technique. When blood is expelled forcefully through a needle tip into an open tube, or when it is vigorously shaken after transfer, red blood cells are subjected to shear stress that causes rupture.
Intracellular contents, particularly potassium and lactate dehydrogenase, are released into the serum, producing falsely elevated results. According to data published in Clinical Chemistry and Laboratory Medicine, hemolysis is the leading cause of specimen rejection in clinical laboratories, affecting an estimated 3 to 14 percent of all samples.
Vacuum collection tubes contain specific additives, anticoagulants such as EDTA, citrate, or heparin, as well as clot activators and gel separators, calibrated to the tube’s dead space and draw volume.
When blood is transferred without attention to tube order or when excess volume is used, additive-to-blood ratios are distorted. Citrate tubes, used for coagulation studies including PT and aPTT, are especially sensitive; underfilling by as little as 10 percent can prolong clotting times and generate spurious coagulation results.
Delay between syringe fill and transfer, or turbulent mixing during transfer, can initiate clot formation in tubes intended for plasma or whole blood analysis.
In blood culture workflows, an aggressive injection technique can introduce air into anaerobic culture bottles, suppressing the growth of obligate anaerobes and producing false-negative results. Conversely, using a needle to puncture a culture bottle stopper without a dedicated transfer device heightens both contamination risk and needlestick exposure.
A closed blood transfer device is designed to bridge the syringe and vacuum collection tube within a sealed system, eliminating the open-air transfer step entirely. The device connects to the syringe via a luer interface and houses an internal needle that punctures the tube stopper when the tube is engaged. The vacuum within the tube draws blood directly from the syringe, controlling both fill volume and flow rate.
Purpose-built devices such as the RELI® Blood Transfer Device from MYCO Medical exemplify this design. The internal needle remains shielded within the device body throughout the transfer, the safety tube holder accommodates standard collection tubes and long-neck blood culture bottles in sequence, and the single-use construction eliminates cross-contamination risk between patients. These design features translate directly into clinical safety outcomes:
The evidence supporting closed transfer devices is consistent with broader laboratory quality improvement literature. Evaluations published in the Journal of Clinical Pathology and related sources have demonstrated measurable reductions in hemolysis rates when closed transfer systems replace open technique.
Proper device selection requires attention to the luer connector type on both the syringe and the transfer device. Luer connections are standardized globally under ISO 80369, but directionality—male versus female—determines compatibility.
A male luer connector has a protruding tip; it mates with a female luer port. A female luer connector has a recessed receptacle; it accepts a male luer tip. Mismatched connections result in insecure fittings, blood leakage, and potential exposure.
For this reason, MYCO Medical offers the RELI® Blood Transfer Device in two distinct configurations to match the full range of syringes encountered in clinical practice.
The RELI® Blood Transfer Device, Male Luer is indicated for syringes with female luer ports. It features a colored protective cap for secure attachment confirmation and supports peripheral IV
line draws as well as Foley catheter urine collection.
The RELI® Blood Transfer Device, Female Luer is designed for syringes with male luer tips, offering the same closed-system protection and internal needle design. Both are manufactured without PVC, DEHP, or natural rubber latex—a specification that supports allergy-aware procurement—and are packaged at 200 units per box with four boxes per case for high-volume institutional purchasing.
Clinicians and materials managers should verify connector compatibility during device selection and ensure that formulary procurement accounts for the full range of syringe types in clinical use at their institution.
Even with a well-designed closed transfer device in hand, technique errors can undermine safety and specimen integrity. The following steps reflect current best practice guidance from clinical laboratory standards organizations, including the Clinical and Laboratory Standards Institute (CLSI).
Blood begins to change immediately upon collection. Platelet activation, cellular metabolism, and potential clot formation begin within minutes. Transfer should occur as promptly as possible after the draw—ideally within two minutes for coagulation tubes and no longer than five minutes for other tube types.
Do not transfer blood through the venipuncture needle. Needle removal should be performed using a safety mechanism or a dedicated needle removal device—never with an unprotected two-handed recap. Once safely removed or retracted, attach the closed transfer device to the syringe luer port.
CLSI H03-A6 order-of-draw guidance applies equally to tube transfer. Blood culture bottles should be filled first to minimize contamination risk, followed by coagulation (citrate) tubes, then other additives, and finally EDTA tubes. Adhering to the order of draw during transfer prevents additive carryover between tube types.
Do not manually depress the plunger while the tube is engaged. The tube’s evacuated space will draw the appropriate volume of blood without assistance. Forcing blood by compressing the plunger introduces positive pressure that can disrupt the stopper seal, cause aerosol generation, and produce overfilled tubes with distorted additive ratios.
Immediately after removing the filled tube, invert it gently the number of times specified by the manufacturer—typically three to eight inversions depending on tube type. Inversion, not shaking, ensures even additive distribution without lysing cells.
After use, discard the entire closed transfer device assembly into an approved sharps container without disassembly. Do not recap, bend, or remove any component. The internal needle remains protected within the device housing, but the entire unit constitutes a sharps waste item.
Syringe-based blood collection is a permanent and necessary feature of clinical practice. The risks it presents—to clinicians through needlestick exposure and to laboratories through pre-analytical error—are not inherent to the method itself but to how the transfer step is executed. Closed blood transfer devices, used in conjunction with disciplined technique and institutional standardization, resolve both categories of risk with a straightforward and cost-effective intervention.
For healthcare organizations committed to occupational safety, specimen quality, and regulatory compliance, closed transfer devices represent not an upgrade but a standard of care. The World Health Organization's Best Practices for Phlebotomy provides a globally applicable framework that supports this standard, and procurement teams, clinical educators, and frontline phlebotomists all have a role in ensuring it is met consistently—at every draw, for every patient.
Interested in testing out purpose-built blood transfer devices? Request a sample or contact our Sales team to make a purchase.
.png)
.png)
.jpg)